IDXX logo

IDEXX Laboratories, Inc. Stock Price

NasdaqGS:IDXX Community·US$50.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 46 Fair Values set on narratives written by author

IDXX Share Price Performance

US$627.28
151.75 (31.91%)
20.1% undervalued intrinsic discount
US$785.00
Fair Value
US$627.28
151.75 (31.91%)
18.0% undervalued intrinsic discount
US$765.08
Fair Value
Price US$627.28
AnalystHighTarget US$765.08
AnalystConsensusTarget US$695.09
AnalystLowTarget US$417.08

IDXX Community Narratives

AnalystHighTarget·
Fair Value US$785 20.1% undervalued intrinsic discount

Global Pet Ownership And AI Diagnostics Will Expand Market Opportunities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystConsensusTarget·
Fair Value US$695.09 9.8% undervalued intrinsic discount

Advanced Diagnostics And International Expansion Will Define Future Opportunity

0users have liked this narrative
0users have commented on this narrative
18users have followed this narrative
AnalystLowTarget·
Fair Value US$497.21 26.2% overvalued intrinsic discount

Declining Pet Ownership And Rising Compliance Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent IDXX News & Updates

IDEXX Laboratories: Recurring Revenue And Market Moat - Why I Choose To Buy

Oct 02

Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25%

Aug 16
Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25%

IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 07
IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

Jul 23
At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

IDEXX Laboratories, Inc. Key Details

US$4.0b

Revenue

US$1.6b

Cost of Revenue

US$2.5b

Gross Profit

US$1.5b

Other Expenses

US$985.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 03, 2025
Earnings per share (EPS)
12.32
Gross Margin
61.54%
Net Profit Margin
24.41%
Debt/Equity Ratio
75.7%

IDEXX Laboratories, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Outstanding track record with excellent balance sheet.

2 Risks
2 Rewards

About IDXX

Founded
1983
Employees
11000
CEO
Jonathan Mazelsky
WebsiteView website
www.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
The Healthcare sector gained 3.7% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›